Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits are low. Learn how it works, why prices are high, and what’s changing in 2026.
26 Feb
Ketamine and Esketamine: Rapid-Acting Options for Depression
8 Mar
How to Identify High-Alert Medications Requiring Double Checks in Clinical Practice
7 Jun
Retail vs Hospital Pharmacy: Key Differences in Medication Substitution
24 Jun
FDA Facility Inspections: How the Agency Ensures Quality and Safety
5 Jul
Buprenorphine Side Effects: Understanding the Ceiling Effect and Safety Profile